Markets:

Overview

News

Currencies

International

Treasuries

Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

2.325 +0.095 (+4.26%)

Streaming Delayed Price Updated: 10:09 AM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

popEVE AI: Harvard-Developed Model Set to Revolutionize Rare Disease Diagnosis and Drug Discovery

November 25, 2025

Cambridge, MA & Barcelona, Spain – November 25, 2025 – A groundbreaking artificial intelligence model, popEVE, developed by a collaborative team of researchers from Harvard Medical School and the...

Via TokenRing AI

Topics Artificial Intelligence

PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after a Politico report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. The proposal would extend subsidies...

Via StockStory

Topics Economy

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

3 Healthcare Stocks We Approach with Caution

November 17, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

3 of Wall Street’s Favorite Stocks We Approach with Caution

November 13, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Topics Retirement

Why PacBio (PACB) Shares Are Getting Obliterated Today

November 12, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) fell 7.5% in the afternoon session after the market continued to react negatively to the company's third-quarter financial...

Via StockStory

Stocks making big moves yesterday: Bumble, Five Below, PacBio, ON24, and Yum China

November 12, 2025

Check out the companies making headlines yesterday:

Via StockStory

5 Revealing Analyst Questions From PacBio’s Q3 Earnings Call

November 12, 2025

PacBio’s third quarter was met with a significant negative market reaction, reflecting disappointment over revenue that fell short of Wall Street expectations. Management attributed the...

Via StockStory

Topics Earnings

Why PacBio (PACB) Stock Is Up Today

November 11, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2.8% in the afternoon session after an analyst at Stephens & Co. raised the price target on the stock while maintaining...

Via StockStory

Topics Artificial Intelligence Supply Chain

Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3

November 10, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at PacBio (NASDAQ:PACB) and the best and worst...

Via StockStory

Topics Artificial Intelligence

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 06, 2025

Via Benzinga

PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus

November 06, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 3.8% year on year to $38.44 million. Its non-GAAP loss of...

Via StockStory

PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings

November 05, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 3.8% year on year to $38.44 million. Its non-GAAP loss...

Via StockStory

PacBio Earnings: What To Look For From PACB

November 03, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday after market close. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

PacBio (PACB) Shares Skyrocket, What You Need To Know

October 31, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 17.9% in the afternoon session after its positive momentum continued as it was disclosed that Cathie Wood's investment...

Via StockStory

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 31, 2025

Via Benzinga

Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday ↗

October 31, 2025

Via Benzinga

Cathie Wood Just Dumped $7.4 Million Worth Of Palantir And AMD Shares — Here's What Ark Is Buying Instead ↗

October 30, 2025

Ark Invest made significant trades involving PLTR, AMD, PACB, and DASH. They sold Palantir and bought AMD, Pacific Biosciences, DoorDash, Iridium, Intellia, Deere, and Synopsys.

Via Benzinga

PacBio (PACB) Stock Is Up, What You Need To Know

October 24, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 4.4% in the afternoon session after the company received a significant vote of confidence from Cathie Wood's ARK...

Via StockStory

Topics Artificial Intelligence

3 Cash-Burning Stocks with Open Questions

October 23, 2025

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to...

Via StockStory

LifeStance Health Group, Azenta, PacBio, GE HealthCare, and ICU Medical Shares Are Falling, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

PacBio (PACB) Stock Trades Up, Here Is Why

October 13, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 5.4% in the afternoon session after the company announced its HiFi sequencing technology was selected as the primary...

Via StockStory

Topics Economy Government Stocks

Why Is PacBio (PACB) Stock Soaring Today

October 08, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 9.3% in the morning session after the National Institute on Aging's Long Life Family Study (LLFS) selected its...

Via StockStory

Applied Materials, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

October 03, 2025

Via Benzinga

Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI

October 01, 2025

San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

AI Takes Center Stage in Biodefense: DARPA's NODES Program Promises to Revolutionize Pandemic and Biowarfare Protection

September 25, 2025

In a groundbreaking leap for global health security, the Defense Advanced Research Projects Agency (DARPA) officially launched its Network of Optimal Dynamic Energy Signatures (NODES) program in July...

Via MarketMinute

Topics Artificial Intelligence

3 Small-Cap Stocks with Questionable Fundamentals

September 25, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

PacBio (PACB) Stock Is Up, What You Need To Know

September 15, 2025

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2% in the pre market session after the stock extended its positive momentum as the company partnered with DKSH and...

Via StockStory

Topics Artificial Intelligence Economy

Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest

September 14, 2025

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life sciences tools & services industry, including PacBio (NASDAQ:PACB) and its...

Via StockStory

Topics Artificial Intelligence Economy

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.